Novo Nordisk A/S

Novo Nordisk A/Sverified

NONOF

Price:

$44.01

Market Cap:

$1.27T

Novo Nordisk A/S operates as a prominent global pharmaceutical firm, dedicated to the discovery, development, production, and distribution of a wide array of medicinal products. Its extensive operations are primarily structured into two distinct divisions: Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment offers comprehensive solutions, encompassing various insulin preparations, GLP-1 receptor agonists along with their delivery systems, oral antidiabetic medications, treatments for weight management, and therapies addressing other chronic health conditions. Meanwhile, the Biopharmaceuticals division is focused on specialized treatments for hemophilia, g...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2010-05-07

Stock Exchange

OTC

Ticker

NONOF

The Enterprise Value as of June 2026 (TTM) for Novo Nordisk A/S (NONOF) is 1.39T

According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 1.39T. This represents a change of -12.03% compared to the average of 1.58T of the last 4 quarters.

Novo Nordisk A/S (NONOF) Historical Enterprise Value (quarterly & annually)

How has NONOF Enterprise Value performed in the past?

The mean historical Enterprise Value of Novo Nordisk A/S over the last ten years is 1.55T. The current 1.39T Enterprise Value has changed 8.92% with respect to the historical average. Over the past ten years (40 quarters), NONOF's Enterprise Value was at its highest in in the June 2024 quarter at 4.48T. The Enterprise Value was at its lowest in in the March 2017 quarter at 581.59B.

Quarterly (TTM)
Annual

Average

1.55T

Median

1.27T

Minimum

625.92B

Maximum

3.14T

Novo Nordisk A/S (NONOF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novo Nordisk A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.57%

Maximum Annual Enterprise Value = 3.14T

Minimum Annual Increase = -45.96%

Minimum Annual Enterprise Value = 625.92B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.55T-45.96%
20242.87T-8.75%
20233.14T46.96%
20222.14T25.45%
20211.70T71.57%
2020993.33B9.52%
2019907.01B25.77%
2018721.16B-10.84%
2017808.80B29.22%
2016625.92B-38.16%

Novo Nordisk A/S (NONOF) Average Enterprise Value

How has NONOF Enterprise Value performed in the past?

The current Enterprise Value of Novo Nordisk A/S (NONOF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.52T

5-year avg

2.28T

10-year avg

1.55T

Novo Nordisk A/S (NONOF) Enterprise Value vs. Peers

How is NONOF’s Enterprise Value compared to its peers?

Novo Nordisk A/S’s Enterprise Value is greater than Novartis AG (329.13B), greater than Sartorius Stedim Biotech S.A. (19.29B), greater than CSL Limited (47.30B), greater than Roche Holding AG (286.98B), greater than Roche Holding AG (286.98B), greater than AstraZeneca PLC (304.11B), greater than Fresenius SE & Co. KGaA (31.83B), greater than Roche Holding AG (286.98B), greater than CSL Limited (47.30B), greater than EssilorLuxottica S.A. (93.93B),

CompanyEnterprise ValueMarket cap
329.13B$276.67B
19.29B$194.17B
47.30B$71.33B
286.98B$327.35B
286.98B$328.87B
304.11B$294.40B
31.83B$100.21B
286.98B$321.58B
47.30B$34.66B
93.93B$92.83B

Build a custom stock screener for Novo Nordisk A/S (NONOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novo Nordisk A/S (NONOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Novo Nordisk A/S's Enterprise Value?

What is the highest Enterprise Value for Novo Nordisk A/S (NONOF)?

What is the 3-year average Enterprise Value for Novo Nordisk A/S (NONOF)?

What is the 5-year average Enterprise Value for Novo Nordisk A/S (NONOF)?

How does the current Enterprise Value for Novo Nordisk A/S (NONOF) compare to its historical average?